Brief: Tianjin Development Says FY Total Operating Income RMB1.15 Bln
22/03/2024 01:27
March 22 (Reuters) - Tianjin Development:
* FY TOTAL OPERATING INCOME RMB1.15 BILLION VERSUS RMB1.15
BILLION
FOR TIANJIN LISHENG PHARMACEUTICAL CO LTD
* TIANJIN LISHENG PHARMACEUTICAL CO'S FY NET PROFIT
ATTRIBUTABLE
RMB361.8 MILLION VERSUS RMB93.6 MILLION
* TIANJIN LISHENG PHARMACEUTICAL PROPOSED CASH DIVIDEND OF
RMB6.00
(TAX INCLUSIVE) FOR EVERY 10 SHARES
Further company coverage: 002393.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln